Evaluation of the Waters MassTrak LC–MS/MS Assay for Tacrolimus and a Comparison to the Abbott Architect Immunoassay

Abstract

Two widely used assays for therapeutic drug monitoring of tacrolimus are not in agreement with one another. Care should be exercised when interpreting results generated on these 2 assay platforms.